Explore how human-relevant liver models can improve DILI risk assessment and support stronger development decisions while advancing toward regulatory qualification.
Macrocycles expand drug discovery into previously inaccessible targets. With validated success and flexible approaches, they provide a powerful path for tackling the most challenging biology.
Discover a suite of services designed to accelerate drug discovery and development, from custom reagent production and high-throughput screening to advanced in vitro pharmacology.
Uncover the challenges when moving a bioconjugate candidate from early development to clinic, along with integrated solutions for navigating this growing area of the industry.
Overcome protein expression bottlenecks with a scalable insect-based platform that delivers faster development, predictable scale-up, and consistent manufacturing.
